Fair 75°
Tag:

Clinical Trial

News
Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial
Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial More than 15 rectal cancer patients who participated in a drug trial at Memorial Sloan Kettering Cancer Center are in remission. The first patient to try the drug was Washington DC's Sascha Roth, who got the good news on a Friday evening just four weeks before she was scheduled to undergo weeks of radiation therapy. More than a dozen others would soon receive the good news. The MSK clinical trial was investigating if immunotherapy alone could beat rectal cancer that had not spread to other tissues, in a subset of patients whose tumor contained a specific genetic mutation, the hospital sai…

SHARE

by Cecilia Levine
News
NJ-Based Johnson & Johnson Pauses COVID-19 Vaccine Trial Due To Unexplained Participant Illness NJ-Based Johnson & Johnson Pauses COVID-19 Vaccine Trial Due To Unexplained Participant Illness
Nj-based Johnson & Johnson Pauses Covid-19 Vaccine Trial Due To Unexplained Participant Illness New Jersey-based Johnson & Johnson has paused its COVID-19 vaccine study because of an unexplained illness among a participant. Researchers running the 60,000 patient trial received a notice saying the "pausing rule has been met," Stat News reports. The online patient-enrolling system was subsequently closed and a meeting for the patient safety monitoring board comprised of independent committee met Monday evening, the report says. J&J -- based in New Brunswick -- declined to tell Stat News anything more than a study participant suffered an unexplained illness. The company began e…

SHARE

by Cecilia Levine